|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ten years experience with alendronate for osteoporosis in postmenopausal women显示文摘 | Bone H G Hosking D Devogelaer J P | 2004 | N Engl J Med2004，350，12： | 1 |
| 2 | Oral alendroaate in 2 duces progressive increases in bone mass of the spine, hip, and totalbody over 3 years in postmenopausal women with osteoporosis显示文摘 | Devogelaer J P Broil H Correa-Rotter R | 1996 | Bone1996，18，2： | 1 |
| 3 | A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis显示文摘 | | 1998 | Drug Saf1998，19，2： | 1 |
| 4 | Inhomogeneity of human vertebral cancelous bone:systematic density and structure patterns inside the vertebral body显示文摘 | Devogelaer J P Munting E | 2000 | Bone2000，28，5： | 1 |
| 5 | Ten years experience with alendronate for osteoporosis in postmenopausal women显示文摘 | Bone H G Hosking D Devogelaer J P | 2004 | N Engl J Med2004，350，： | 1 |
| 6 | Cross-link profile of bone collagen correlates with structural organization of trabeculae显示文摘 | BANSE X DEVOGELAER J P LAFOSSE A | 2002 | Bone2002，31，1： | 1 |
| 7 | Fluoride the-rapy of type Ⅰosteoporosis 显示文摘 | Devogelaer J P de Deuxchaisnes C N | 1995 | Clin Rheumatol1995，14，3： | 1 |
| 8 | Ten years experience with alendronate for osteopomsis in postmenopausal women 显示文摘 | Bone H G Hosking D Devogelaer J P | 2004 | N Engl J Med2004，350，12： | 1 |
| 9 | Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men显示文摘 | Devogelaer J P Boutsen Y Manicourt D H | 2010 | Current Osteoporosis Report2010，8，3： | 1 |
| 10 | Ten years’experiencewith alendronate for osteoporosis in postmenopausal women显示文摘 | Bone H G Hosking D Devogelaer J P | 2004 | N Engl JMed2004，350，12： | 1 |
| 11 | Zoledronic acid and risedronate in the prevention and treatment of glucocorti- coid - induced osteoporosis ( HORIZON ) : a multicentre, double-blind, double-dummy, randomised controlled trial 显示文摘 | Reid D M Devogelaer J P Saag K | 2009 | The Lancet2009，373，9671： | 1 |
| 12 | Ten years' experience with alendronate for osteoporosis in postmenopausal women 显示文摘 | Bone H G Hosking D Devogelaer j P | 2004 | N Engl J Med2004，350，12： | 1 |
| 13 | Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial显示文摘 | Saag K G Zanchetta J R Devogelaer J P | 2009 | Arthritis Rheum2009，60，11： | 1 |
| 14 | Ten years' experience with alendronate for osteoporosis in postmenopausal women显示文摘 | BONE H G HOSKING D DEVOGELAER J P | 2004 | NEnglJMed2004，350，12： | 1 |
| 15 | Zoledronlc acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis(HORIZON) a multicentre, double-blind, double-dummy, randomised controlled trial显示文摘 | Reid D M Devogelaer J P Saag K Roux C Lau C S Reginster J Y | 2009 | Lancet2009，373，： | 1 |
| 16 | Ten years expe- rience with alendronate for osteoporosis in postmenopaus- al women显示文摘 | Bone H G Hosking D Devogelaer J P | 2004 | N Engl J Med2004，350，12： | 1 |
| 17 | Inhomogeneity of human vertebral cancellous bone:systematic density and structure patterns inside the vertebral body显示文摘 | Banse X Devogelaer J P Munting E | 2001 | Bone2001，28，5： | 1 |
| 18 | Treatment with calcitonin prevents the net loss of collagen,hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis显示文摘 | Hajjaji H Williams J M Devogelaer J P | 2004 | Osteoarthritis And Cartilage2004，12，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员